Anzeige
Meldung des Tages: Unter dem Radar, voll finanziert: Beginnt jetzt der nächste Gold-Run?

Rocket Pharma. News

Aktie
WKN:  A2JA9Q ISIN:  US77313F1066 US-Symbol:  RCKT Branche:  Biotechnologie Land:  USA
3,13 €
+0,03 €
+0,97%
19:38:09 Uhr
Depot/Watchlist
Marktkapitalisierung *
318,98 Mio. €
Streubesitz
6,08%
KGV
-4,74
Index-Zuordnung
-

Rocket Pharmaceuticals News

09.12.25 - PR Newswire
Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions
Beyond Traditional Drugs: Novel Platforms Targeting Hard-​to-Treat Conditions PR Newswire
19.09.25 - PR Newswire
Kuehn Law Encourages Investors of Rocket Pharmaceuticals, Inc. to Contact Law Firm
Kuehn Law Encourages Investors of Rocket Pharmaceuticals, Inc. to Contact Law Firm PR Newswire
11.08.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKT
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - ...
11.08.25 - PR Newswire
Class Action Filed Against Rocket Pharmaceuticals, Inc. (RCKT) - August 11, 2025 Deadline to Join - Contact The Gross Law Firm
Class Action Filed Against Rocket Pharmaceuticals, Inc. (RCKT) - August 11, 2025 Deadline to Join - Contact The Gross Law Firm PR Newswire
10.08.25 - PR Newswire
RCKT Deadline: RCKT Investors with Losses in Excess of $100K Have Opportunity to Lead Rocket Pharmaceuticals, Inc. Securities Fraud Lawsuit
RCKT Deadline: RCKT Investors with Losses in Excess of $100K Have Opportunity to Lead Rocket Pharmaceuticals, Inc. Securities Fraud Lawsuit PR Newswire
09.08.25 - PR Newswire
Faruqi & Faruqi Reminds Rocket Pharmaceuticals Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 11, 2025 - RCKT
Faruqi & Faruqi Reminds Rocket Pharmaceuticals Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 11, 2025 - RCKT PR Newswire
08.08.25 - PR Newswire
DEADLINE NEXT WEEK: Berger Montague Advises Rocket Pharmaceuticals (NASDAQ: RCKT) Investors to Contact the Firm Before August 11, 2025
DEADLINE NEXT WEEK: Berger Montague Advises Rocket Pharmaceuticals (NASDAQ: RCKT) Investors to Contact the Firm Before August 11, 2025 PR Newswire
08.08.25 - PR Newswire
August 11, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against RCKT
August 11, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against RCKT PR Newswire
07.08.25 - PR Newswire
Lost Money on Rocket Pharmaceuticals, Inc.(RCKT)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
Lost Money on Rocket Pharmaceuticals, Inc.(RCKT)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm PR Newswire
06.08.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKT
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - ...
05.08.25 - PR Newswire
DEADLINE APPROACHING: Berger Montague Advises Rocket Pharmaceuticals (NASDAQ: RCKT) Investors to Inquire About a Securities Fraud Class Action by August 11, 2025
DEADLINE APPROACHING: Berger Montague Advises Rocket Pharmaceuticals (NASDAQ: RCKT) Investors to Inquire About a Securities Fraud Class Action by August 11, 2025 PR ...
05.08.25 - PR Newswire
RCKT Deadline: RCKT Investors with Losses in Excess of $100K Have Opportunity to Lead Rocket Pharmaceuticals, Inc. Securities Fraud Lawsuit
RCKT Deadline: RCKT Investors with Losses in Excess of $100K Have Opportunity to Lead Rocket Pharmaceuticals, Inc. Securities Fraud Lawsuit PR Newswire
05.08.25 - PR Newswire
Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire
05.08.25 - PR Newswire
Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before August 11, 2025 to Discuss Your Rights - RCKT
Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before August 11, 2025 to Discuss Your Rights - RCKT PR Newswire
04.08.25 - PR Newswire
DEADLINE NEXT WEEK: Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
DEADLINE NEXT WEEK: Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit PR Newswire
04.08.25 - PR Newswire
Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - RCKT
Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - RCKT PR Newswire
03.08.25 - PR Newswire
RCKT Investors Have the Opportunity to Lead the Rocket Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
RCKT Investors Have the Opportunity to Lead the Rocket Securities Fraud Lawsuit with Faruqi & Faruqi, LLP PR Newswire
01.08.25 - PR Newswire
Levi & Korsinsky Notifies Rocket Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - RCKT
Levi & Korsinsky Notifies Rocket Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - RCKT PR Newswire
01.08.25 - PR Newswire
ROCKET PHARMACEUTICALS (NASDAQ: RCKT) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by August 11, 2025
ROCKET PHARMACEUTICALS (NASDAQ: RCKT) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action ...
31.07.25 - PR Newswire
RCKT Deadline: RCKT Investors with Losses in Excess of $100K Have Opportunity to Lead Rocket Pharmaceuticals, Inc. Securities Fraud Lawsuit
RCKT Deadline: RCKT Investors with Losses in Excess of $100K Have Opportunity to Lead Rocket Pharmaceuticals, Inc. Securities Fraud Lawsuit PR Newswire

Newssuche

Videos

newspaper
07.04.26 +3,81%
Technical Trading: DAX Long kurzfristig
DAX Long Typ: Turbo Open End WKN: VJ9H40 Hebel:11,30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »